Protalix Biotherapeutics, Inc. (PLX)

2.10 +0.01 (+0.48%) USD  |  NYAM  |  Jan 23, 14:25
More

Protalix Biotherapeutics Operating Income (Quarterly YoY Growth)

Operating Income (Quarterly YoY Growth) Chart

View Operating Income (Quarterly YoY Growth) for PLX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Operating Income (Quarterly YoY Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Operating Income (Quarterly YoY Growth) Range, Past 5 Years

View Operating Income (Quarterly YoY Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Operating Income (Quarterly YoY Growth) Benchmarks

View Operating Income (Quarterly YoY Growth) Benchmarks
Start Trial
OraSure Technologies, Inc. Upgrade
PAVmed, Inc. Upgrade
Denali Therapeutics, Inc. Upgrade
AIM ImmunoTech, Inc. Upgrade
Armata Pharmaceuticals, Inc. Upgrade